PureTech Health plc (PRTC)

PureTech Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	4.83	3.33	15.62	17.39	11.77
Revenue Growth (YoY)	44.98%	-78.68%	-10.18%	47.76%	20.00%
Cost of Revenue	69.23	94.98	152.43	110.47	-
Gross Profit	-64.4	-91.65	-136.82	-93.08	11.77
Selling, General & Admin	71.47	53.3	60.99	57.2	49.44
Research & Development	-	-	-	-	81.86
Operating Expenses	71.47	53.3	60.99	57.2	131.3
Operating Income	-135.87	-144.94	-197.81	-150.28	-119.53
Interest Expense	-10.04	-13.49	-3.95	-4.71	-2.95
Interest & Investment Income	22.67	16.01	5.8	0.21	1.18
Earnings From Equity Investments	4.38	-33.69	-27.75	-73.7	-34.12
Currency Exchange Gain (Loss)	-0.03	-0.09	0.01	-0.06	-
Other Non Operating Income (Expenses)	-7.15	1.74	145.19	11.2	-3.32
EBT Excluding Unusual Items	-126.03	-174.45	-78.5	-217.34	-158.73
Gain (Loss) on Sale of Investments	-2.05	77.82	-41.53	158.39	177.7
Gain (Loss) on Sale of Assets	151.81	61.79	27.25	-	-
Asset Writedown	-0.23	-1.26	-	-	-
Other Unusual Items	0.27	-	-	-	-
Pretax Income	23.77	-36.1	-92.78	-58.95	18.97
Income Tax Expense	-4.01	30.53	-55.72	3.76	14.4
Earnings From Continuing Operations	27.78	-66.63	-37.06	-62.71	4.57
Minority Interest in Earnings	25.73	0.93	-13.29	2.15	1.42
Net Income	53.51	-65.7	-50.35	-60.56	5.99
Net Income to Common	53.51	-65.7	-50.35	-60.56	5.99
Net Income Growth	-	-	-	-	-98.58%
Shares Outstanding (Basic)	254	276	285	287	286
Shares Outstanding (Diluted)	256	276	285	287	293
Shares Change (YoY)	-7.34%	-2.97%	-0.64%	-2.14%	0.37%
EPS (Basic)	0.21	-0.24	-0.18	-0.21	0.02
EPS (Diluted)	0.21	-0.24	-0.18	-0.21	0.02
EPS Growth	-	-	-	-	-98.61%
Free Cash Flow	-134.38	-105.99	-180.97	-163.85	-137
Free Cash Flow Per Share	-0.53	-0.38	-0.64	-0.57	-0.47
Gross Margin	-	-	-	-	100.00%
Operating Margin	-2814.19%	-4352.55%	-1266.53%	-864.29%	-1015.73%
Profit Margin	1108.33%	-1972.88%	-322.41%	-348.27%	50.86%
Free Cash Flow Margin	-2783.35%	-3182.79%	-1158.71%	-942.29%	-1164.15%
EBITDA	-134.06	-141.99	-191.96	-145.93	-115.59
D&A For EBITDA	1.81	2.95	5.85	4.35	3.95
EBIT	-135.87	-144.94	-197.81	-150.28	-119.53
Effective Tax Rate	-	-	-	-	75.92%
Revenue as Reported	4.83	3.33	15.62	17.39	11.77

Updated Aug 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q